Intravenous Infusions Plc (GHSE:IIL)
0.6400
-0.1400 (-17.95%)
At close: Aug 5, 2026
Intravenous Infusions Cash Flow Statement
Financials in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4.43 | -4.63 | -0.64 | 2.54 | -3.51 | 1.15 |
Depreciation & Amortization | 0.52 | 0.55 | 0.65 | 0.79 | 0.56 | 0.54 |
Other Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
Other Operating Activities | -1.3 | -1.41 | -0.3 | 0.49 | -0.29 | -0.17 |
Change in Accounts Receivable | 5.22 | 4.96 | 4.37 | 0.02 | 0.77 | -1 |
Change in Inventory | -0.94 | 1.55 | 0.17 | 0.37 | 1.03 | -1.59 |
Change in Accounts Payable | -3.75 | -1.37 | 3.23 | 0 | 4.3 | 4.37 |
Operating Cash Flow | -4.68 | -0.34 | 7.5 | 4.23 | 2.87 | 3.3 |
Operating Cash Flow Growth | - | - | 77.29% | 47.23% | -12.91% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.52 | -0.53 | -1.9 | -1.84 | -2.42 | -7.16 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | 0.01 | - | 0.06 | - |
Cash Acquisitions | - | - | - | -0.01 | - | - |
Sale (Purchase) of Intangibles | - | - | -0 | -0.02 | -0.01 | - |
Investing Cash Flow | -0.51 | -0.51 | -1.89 | -1.87 | -2.37 | -7.16 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 2 | - |
Long-Term Debt Issued | - | - | - | - | - | 5.75 |
Total Debt Issued | 4.2 | - | - | - | 2 | 5.75 |
Short-Term Debt Repaid | - | -0.46 | -0.71 | -1.09 | -0.23 | - |
Long-Term Debt Repaid | - | -0.01 | -3.95 | -2.62 | -1.91 | -1.33 |
Total Debt Repaid | 0.41 | -0.47 | -4.66 | -3.71 | -2.14 | -1.33 |
Net Debt Issued (Repaid) | 4.61 | -0.47 | -4.66 | -3.71 | -0.14 | 4.42 |
Common Dividends Paid | -0.15 | -0.15 | -0.1 | - | -0.09 | -0.71 |
Other Financing Activities | 0.01 | 0.01 | 0.35 | 0.69 | -0.13 | - |
Financing Cash Flow | 4.46 | -0.61 | -4.41 | -3.02 | -0.36 | 3.71 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | -0.72 | -1.46 | 1.19 | -0.66 | 0.15 | -0.15 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.2 | -0.87 | 5.59 | 2.39 | 0.45 | -3.86 |
Free Cash Flow Growth | - | - | 134.56% | 427.29% | - | - |
Free Cash Flow Margin | -79.84% | -9.38% | 22.43% | 7.59% | 2.22% | -17.03% |
Free Cash Flow Per Share | -0.02 | -0.00 | 0.02 | 0.01 | 0.00 | -0.01 |
Levered Free Cash Flow | -8.99 | -0.29 | 7.17 | 3.3 | 1.77 | -4.24 |
Unlevered Free Cash Flow | -8.91 | -0.22 | 7.26 | 3.75 | 2.02 | -4.14 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 0.27 | 0.27 | 0.46 | 0.46 | 0.26 | 0.46 |
Change in Working Capital | 0.53 | 5.14 | 7.78 | 0.39 | 6.1 | 1.78 |